The global colorectal cancer molecular diagnostics market garnered a market value of USD 2.35 Billion in 2022 and is expected to accumulate a market value of USD 5.07 Billion by registering a CAGR of 8% in the assessment period 2022 to 2032. Growth of the market can be attributed to increasing cases of cancer along with development in diagnostic laboratories.
Report Attribute | Details |
---|---|
Estimated Base Year Value (2021) | USD 2.17 Billion |
Expected Market Value (2022) | USD 2.35 Billion |
Anticipated Forecast Value (2032) | USD 5.07 Billion |
Projected Growth Rate (2022 to 2032) | 8% CAGR |
Approximately 1.4 million new cases of colorectal cancer are diagnosed each year. Obtaining an early diagnosis is critical as it is currently one of the deadliest cancers, totalling more than 600,000 deaths each year.
Colorectal cancer molecular diagnostics can speed up the identification of colorectal cancer to provide patients with more treatment options. Individualized and targeted treatments are reshaping the colorectal molecular diagnostics market. Molecular pathology is a key factor in personalized medicine. This, in turn, is increasing the dependency on colorectal cancer molecular diagnostics.
Increasing adoption of high throughput sequencing technologies and identification of therapeutic targets has led to the development of many colorectal molecular diagnostic tests, which are superior to the conventional colorectal cancer molecular diagnostics tests.
Positive market trends and increasing investor confidence in several key players are helping mergers and acquisition activities in the colorectal cancer molecular diagnostics market. The disruption in the global healthcare market due to political factors such as the Obama Care Act, and regulatory framework changes, and other trade barriers, are anticipated to trigger merger and acquisition activities to drive the colorectal cancer molecular diagnostics market consolidation and further intensify the market competition.
Increase in research in the pharmaceutical and biotechnology industry is contributing to the growth of the colorectal cancer molecular diagnostics market significantly. In addition, growing automation in laboratories is another factor supporting the growth of the colorectal cancer molecular diagnostics market.
Moreover, the ease of use of colorectal cancer molecular diagnostics, as well as accurate results is supporting the growth of the colorectal cancer molecular diagnostics market. All these factors are increasing the use of colorectal cancer molecular diagnostics.
Despite colorectal cancer being common across the globe, many people do not get themselves tested at an early stage. This is owing to the lack of knowledge regarding the problem and its lasting effects on health. In addition, the availability of low-cost alternatives and the high cost of instruments may hinder the growth of the market during the forecast period.
Limited specificity to some diagnostics tests that are unable to distinguish between inflammation and actual symptoms or cancer is another issue being faced by the colorectal cancer molecular diagnostics market.
American Cancer Society states that 52,580 deaths are expected to occur due to colorectal cancer in 2022 in USA the number of people being diagnosed with colorectal cancer is increasing owing to habits such as smoking, drastic diet changes and stress. Moreover, people suffering from hereditary cancer diseases are likely to suffer from cancer in the region. As the awareness regarding getting diagnosed is increasing, more people have shown an inclination to undergo tests. Furthermore, owing to the increasing automation of labs in the region is positively Inflcuening the growth of the market.
Thus, North America is expected to hold the maximum market share and is expected to register a CAGR of 9% for the global colorectal cancer molecular diagnostics market.
The strong and evolving government support towards research in biotechnology and pharmaceutical industry in Asia Pacific especially in countries like India and China are contributing to the growth of colorectal cancer molecular diagnostics. Reports state that the number of people suffering from colorectal cancer are expected to increase by 2035, especially in India.
Thus, the government of the country is taking measures to spread awareness amongst people to get tested at an early stage. The Asia Pacific colorectal cancer molecular diagnostics market is anticipated to grow at a rapid pace with a maximum CAGR of more than 8% over the forecast period.
Some of the key players in the global Colorectal Cancer Molecular Diagnostics market are Dako, Gen Probe (Hologic), Cepheid, Qiagen, Roche Diagnostics, Bayer Healthcare, Abbott Laboratories, Grifols, Guardant Health, Danaher Corporation, Siemens, Beckton Dickinson, Biomérieux Sa, and Sysmex Corporation. Attributed to the presence of such high number of participants, the market is highly competitive.
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 8% from 2022 to 2032 |
Market Value in 2022 | USD 2.35 Billion |
Market Value in 2032 | USD 5.07 Billion |
Base Year for Estimation | 2021 |
Historical Data | 2017 to 2021 |
Forecast Period | 2022 to 2032 |
Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segments Covered | Product Type, Technology, End User, Region |
Regions Covered | North America; Latin America; Europe; Asia Pacific; Middle East and Africa |
Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, ASEAN, GCC, South Africa |
Key Companies Profiled | Dako; Gen Probe (Hologic); Cepheid Qiagen; Roche Diagnostics; Bayer Healthcare; Abbott Laboratories; Grifols, Danaher Corporation; Siemens; Beckton Dickinson; Biomérieux Sa ; Guardant Health; Sysmex Corporation |
Customization | Available Upon Request |
Table 1: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 3: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 4: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 5: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 6: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 7: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 8: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 9: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 10: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 11: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 12: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 13: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 14: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 15: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 16: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 17: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 18: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 19: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 20: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 21: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 22: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 23: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 24: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032
Table 25: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 26: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Product Type, 2017-2032
Table 27: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by Technology, 2017-2032
Table 28: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Forecast by End User, 2017-2032
Figure 1: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032
Figure 2: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 3: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032
Figure 4: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Region, 2022-2032
Figure 5: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 6: Global Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 7: Global Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 8: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 9: Global Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 10: Global Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 11: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 12: Global Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 13: Global Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 14: Global Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 15: Global Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 16: Global Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 17: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032
Figure 18: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 19: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032
Figure 20: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness by Region, 2022-2032
Figure 21: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032
Figure 22: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 23: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032
Figure 24: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 25: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 26: North America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 27: North America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 28: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 29: North America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 30: North America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 31: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 32: North America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 33: North America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 34: North America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 35: North America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 36: North America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 37: North America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032
Figure 38: North America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 39: North America Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032
Figure 40: North America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032
Figure 41: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032
Figure 42: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 43: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032
Figure 44: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 45: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 46: Latin America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 47: Latin America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 48: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 49: Latin America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 50: Latin America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 51: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 52: Latin America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 53: Latin America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 54: Latin America Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 55: Latin America Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 56: Latin America Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 57: Latin America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032
Figure 58: Latin America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 59: Latin America Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032
Figure 60: Latin America Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032
Figure 61: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032
Figure 62: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 63: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032
Figure 64: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 65: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 66: Europe Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 67: Europe Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 68: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 69: Europe Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 70: Europe Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 71: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 72: Europe Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 73: Europe Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 74: Europe Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 75: Europe Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 76: Europe Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 77: Europe Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032
Figure 78: Europe Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 79: Europe Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032
Figure 80: Europe Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032
Figure 81: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032
Figure 82: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 83: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032
Figure 84: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 85: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 86: East Asia Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 87: East Asia Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 88: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 89: East Asia Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 90: East Asia Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 91: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 92: East Asia Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 93: East Asia Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 94: East Asia Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 95: East Asia Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 96: East Asia Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 97: East Asia Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032
Figure 98: East Asia Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 99: East Asia Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032
Figure 100: East Asia Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032
Figure 101: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032
Figure 102: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 103: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032
Figure 104: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 105: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 106: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 107: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 108: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 109: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 110: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 111: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 112: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 113: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 114: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 115: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 116: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 117: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032
Figure 118: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 119: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032
Figure 120: South Asia & Pacific Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032
Figure 121: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Product Type, 2022-2032
Figure 122: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Technology, 2022-2032
Figure 123: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by End User, 2022-2032
Figure 124: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) by Country, 2022-2032
Figure 125: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 126: MEA Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 127: MEA Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 128: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Product Type, 2017-2032
Figure 129: MEA Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Product Type, 2022-2032
Figure 130: MEA Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Product Type, 2022-2032
Figure 131: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by Technology, 2017-2032
Figure 132: MEA Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by Technology, 2022-2032
Figure 133: MEA Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by Technology, 2022-2032
Figure 134: MEA Colorectal Cancer Molecular Diagnostics Market Value (US$ Mn) Analysis by End User, 2017-2032
Figure 135: MEA Colorectal Cancer Molecular Diagnostics Market Value Share (%) and BPS Analysis by End User, 2022-2032
Figure 136: MEA Colorectal Cancer Molecular Diagnostics Market Y-o-Y Growth (%) Projections by End User, 2022-2032
Figure 137: MEA Colorectal Cancer Molecular Diagnostics Market Attractiveness by Product Type, 2022-2032
Figure 138: MEA Colorectal Cancer Molecular Diagnostics Market Attractiveness by Technology, 2022-2032
Figure 139: MEA Colorectal Cancer Molecular Diagnostics Market Attractiveness by End User, 2022-2032
Figure 140: MEA Colorectal Cancer Molecular Diagnostics Market Attractiveness by Country, 2022-2032
FMI projects the global colorectal cancer molecular diagnostics market to expand at an 8% value CAGR by 2032
North America is expected to be the most opportunistic colorectal cancer molecular diagnostics market, expanding at a 9% CAGR
Dako, Gen Probe (Hologic), Cepheid, Qiagen, Roche Diagnostics, Bayer Healthcare, Abbott Laboratories, Grifols, Danaher Corporation, Siemens, Beckton Dickinson, Biomérieux Sa, and Sysmex Corporation are some prominent colorectal cancer molecular diagnostics market.
Explore In-vitro Diagnostics Devices Insights
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.